KVUE today
$19.31-$0.25 (-1.28%)close Oct 30, 2026Trend
DailyDowntrend (confirmed)
4 hourBearish
1 hourExpanding
15 minSymmetric Triangle
5 minExpanding
Daily trend turns up above $18.08
Key levels
Resistance$20.69
Resistance$19.89
Support$19.18
Support$18.71
Latest news & SEC filings
AnalystUBS kept its Neutral rating on Kenvue (KVUE) and raised its price target to $20 from $19.
All KVUE news →About Kenvue
Kenvue is a consumer health company that makes over-the-counter medicines, skin and hair care products, and personal care items. Its brands include Tylenol, Listerine, Neutrogena, Aveeno, Band-Aid, and Johnson's. The company sells through retailers and online in North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America.
Based on the company's 10-K filed Feb 20, 2026.
NYSE · Consumer Defensive
Kenvue Inc. (KVUE)
What Is the Price Target for KVUE?
SEPT Low Target
$19.00
SEPT Mid Target
$19.00
SEPT High Target
$19.00
Analyst Consensus
$19.00
Is KVUE a Buy or Sell Right Now?
Thesis
- •Revenue growing -2.1% YoY with SLOWING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for KVUE.
Start Free Trial →Is KVUE Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$22.30
45
Moat Score
NARROW
6/9
Piotroski Score
2.2
Altman Z-Score
What Is Smart Money Doing with KVUE?
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
BUYING
3 buys / 5 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| ALLISON RICHARD E JR | director | Sale | 25,598 | - | Nov 2, 2026 |
| Smith Jeffrey C | director | Sale | 27,307,632 | - | Nov 2, 2026 |
| Perry Kirk | director officer | Sale | 62,555 | - | Nov 2, 2026 |
| Howlett Heather | officer | Sale | 34,603 | - | Nov 2, 2026 |
| Healey Melanie | director | Sale | 151 | - | Nov 2, 2026 |
| Sneed Michael E | director | Sale | 10,787 | - | Nov 2, 2026 |
| Wondrasch Michael | officer | Sale | 45,453 | - | Nov 2, 2026 |
| Tillett Caroline | officer | Sale | 77,709 | - | Nov 2, 2026 |
| Stevens Meredith | officer | Sale | 114,183 | - | Nov 2, 2026 |
| Orlando Matthew | officer | Sale | 20,394 | - | Nov 2, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →KVUE Growth Story
Revenue YoY
-2.1%
3yr Revenue CAGR
0.4%
EPS Growth YoY
40.74%
FCF Growth YoY
29.0%
Revenue Trend
SLOWING
Dark Pool Trades for KVUE
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for KVUE, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:21:51 | $19.31 | 217,217 | $$4.2M | SELL |
| 20:58:30 | $19.31 | 1,005,780 | $$19.4M | SELL |
| 20:21:30 | $19.31 | 6,311 | $$122K | SELL |
| 20:08:35 | $19.31 | 2,606,486 | $$50.3M | SELL |
| 20:05:20 | $19.31 | 21,048 | $$406K | SELL |
5 dark pool trades shown · $$74.5M preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About KVUE
2 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for KVUE. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Smart Money Moves $KVUE — ALLISON RICHARD E JR | Sale $BBTX — Jeggle Helmut Wolfgang | Sale $BBTX — Jeggle Helmut Wolfgang | Sale $6.0M $FCPT — Lenehan William H | Sale $226K $KVUE — Smith Jeffrey C ...
Smart Money Moves $KVUE — ALLISON RICHARD E JR | Sale $GDYN — Doradla Anil | Sale $210K $PUSA — Sinensky Michael | Sale $SCCO — Arrigunaga Gomez del Campo Javier | Sale $SCCO — Valenzuela Rionda Jose...
Join 3,500+ traders discussing KVUE in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Kenvue Inc. (KVUE) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →KVUE — frequently asked questions
What is KVUE stock price today?
Kenvue Inc. (KVUE) is at $19.31, down 1.28% (-$0.25) at the Oct 30, 2026 close.
Why is KVUE stock moving today?
Latest KVUE news — Nov 2, 2026: UBS kept its Neutral rating on Kenvue (KVUE) and raised its price target to $20 from $19.
What is the KVUE price target?
The average analyst price target for KVUE is $19.00, ranging from $19 to $19, based on 2 analysts. Latest: UBS maintains on Aug 11, 2026.
What do analysts rate KVUE?
Analyst ratings for KVUE: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did KVUE beat earnings?
KVUE last reported on Oct 30, 2026: EPS $0.29 vs $0.29 expected — a miss of 0.6%.
What is KVUE's P/E ratio?
KVUE trades at a P/E of 22.2 vs a Consumer Defensive average of 20.4.
Does KVUE pay a dividend?
Yes. KVUE's dividend yield is 4.80%.
What are KVUE support and resistance levels?
Support: $19.18, $18.71, $18.08. Resistance: $19.89, $20.69, $21.32.
What are insiders doing with KVUE?
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
What is the latest news on KVUE?
Nov 2, 2026: UBS kept its Neutral rating on Kenvue (KVUE) and raised its price target to $20 from $19.